M C E

Active Private limited companyfounded 2017active for 9 yearsOudergemlaan 239, 1040 EtterbeekKBO/BCE: BE 0680.438.766

M C E

Follow Report Compare

Overview

Lifetime

9 annual accounts with figures on one time axis

Compare with

peak €47,824 (2024)

€15,584▼ 67.4%

lowest -€24,381 (2023)

€12,291▲ 75.5%

peak €53,728 (2020)

€22,551▲ 29.2%

€9,187▼ 10.7%

peak 0.8 FTE (2019)

-not published

Board5 names since 2017

3 directors and 2 others

Documentsfilings and deeds

22-06-202639 days before the deadline

2025micro format

Gross margin from €47,824 to €15,584Result from €7,005 to €12,291Resignation: (director) 24-01Dividend €7,200Equity from €17,460 to €22,551

Key points

from the 2025 annual accounts

Equity

€22,551 from €53,728 in 2020

Equity fell by 58% in 5 years.

Turnover

≈ €98,000 estimated

The micro format states no turnover.

Liquidity

2.75 was 1.93 in 2024

Short-term debts fell from €10,287 to €9,187.

Filings

9 annual accounts 1 late

The 2017 accounts came 86 days late. The other eight were filed on time.

Position in the sector

€12,291

Lower net result than 81% of companies in human health. Sector median €59,543 · 21,321 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,973 companies had the same profile as M C E has now. Each dot stands for 68 companies, two years later.

94.9%

were still trading

3.5%

stopped another way

1.6%

went bankrupt

Micro
5 to 10 years old
solvency 30% or more
a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group	Expected	Actual
1	0.2%	0.2%
2	0.3%	0.5%
3	0.5%	0.6%
4	0.7%	0.8%
5	0.9%	0.9%
6	1.3%	1.5%
7	1.6%	1.8%
8	1.8%	1.8%
9	2.9%	3.1%
10	5.6%	6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,973 companies, not a prediction for M C E. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager, since 25-08-2017

Director, since 06-03-2018

Director

deed of 23-05-2018

Board & ownership

Recent changes

24-01-2025

Resignation: (director) Board meeting of 02-01-2025 · Gazette deed

20-04-2023

Appointments: (director) and (director) General meeting of 13-04-2023 · Gazette deed

23-05-2018

Appointment: (manager) Transfer of shares from to · General meeting of 2018-03 · Gazette deed

16-10-2017

Resignation: (manager) holds all the shares · General meeting of 30-09-2017 · Gazette deed

All 18 events

Comparable companies

same main activity, similar in size and age

Company
M C E Etterbeek	€31,738	€15,584	71.1%	-
TRAVAGLINI'S GENERAL PRACTICE Anderlecht	€27,756	€19,512	-11.4%	-
Sur Le Chemin Ittre	€31,180	€20,404	88.7%	-
MEDICAL FOCUS Zaventem	€20,917	€15,584	-17.7%	-
DR. VICTOR CAMERLYNCK Antwerp	€37,950	€15,500	28.4%	-
Dr. Kathleen Van Aken Edegem	€39,954	€11,550	90.8%	-
Integraal Healthcare Management Services Antwerp	€50,627	€14,073	34.3%	-

These companies have the same main activity as M C E: general medical practice (NACE 86210). They are comparable in size and age: total assets between €20,900 and €50,600, founded between 2015 and 2021.

Official details

Source: KBO

Status: Active since 25-08-2017Normal situation
Activity: General medical practiceNACE 86210
Joint committee: 330Health institutions and services · annual accounts 2025
Establishment unit: 2.268.658.4671040 Etterbeek, since 01-10-2017
Financial year end: 31 December
Peppol: Not found in the Peppol Directory

Company details

Annual accounts 2025

: €15,584▼ 67.4%
: €12,291▲ 75.5%
: €22,551▲ 29.2%
: €31,738▲ 14.4%
Employeeson 31-12-2025: 1=
Filing: Filed on 22-06-2026, 39 days before the end of the filing period

Financials

Insights on M C E

M C E files the micro format. That format states no turnover. The gross margin fell from €18,621 in 2017 to €15,584 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2025

micro format, filed on 22-06-2026, 39 days before the deadline

€15,584

▼ 67.4%

€12,435

▲ 70.1%

€13,873

▲ 51.5%

€13,729

▲ 55.1%

71.1%

▲ 8.1 percentage points

2.75

▲ 0.82

Money flows

no detail for 2025

Balance sheet

balance sheet total €31,738 on 31-12-2025

What the company ownsHow it is paid for

in euro

Position in the sector

Compare with sector

71.1%

Higher than 58% of 21,334 companies in 2025.

2.75

Higher than 50% of 20,884 companies in 2025.

38.7%

Higher than 74% of 21,184 companies in 2025.

M C E Middle half of the sector 80% of the sector Micro accounts in human health (NACE 86)

Net result: bottom quarter · Equity: bottom quarter · Balance sheet total: bottom quarter · Working capital: middle half

Staff

€1,653

Staff costs divided by the average number of full-time equivalents.

Filed annual accounts

as filed with the National Bank, click a year to choose it

Line	2025	2024	2023	2022	2021	2020	2019	2018	2017
Balance sheet: assets
`20/58`	31,738	27,747	27,210	52,217	68,501	88,237	47,642	50,452	27,283
`21/28`	6,494	7,932	9,779	11,988	14,214	5,372	3,030	5,438	-
`22/27`	6,494	7,932	9,779	11,988	14,214	5,372	3,030	5,438	-
`22`	2,698	2,873	3,049	3,224	3,400	-	-	-	-
`23`	2,846	3,330	3,814	4,298	4,782	-	-	-	-
`24`	950	1,729	2,916	4,466	6,032	5,372	3,030	5,438	-
`29/58`	25,244	19,815	17,431	40,229	54,287	82,865	44,612	45,014	27,283
`40/41`	4,952	-	-	-	4,891	3,023	8,912	7,546	73
`40`	-	-	-	-	-	-	454	-	-
`41`	4,952	-	-	-	4,891	3,023	8,458	7,546	73
`54/58`	18,016	16,069	13,083	31,023	33,993	62,602	27,691	31,123	22,750
`490/1`	2,276	3,746	4,348	9,206	15,403	17,240	8,009	6,345	4,460
Balance sheet: equity and liabilities
`10/49`	31,738	27,747	27,210	52,217	68,501	88,237	47,642	50,452	27,283
`10/15`	22,551	17,460	10,455	34,836	49,932	53,728	40,638	36,324	26,772
`10/11`	12,500	12,500	12,500	12,500	12,500	12,500	12,500	12,500	12,500
`100`	-	-	-	-	-	-	18,600	18,600	18,600
`101`	-	-	-	-	-	-	6,100	6,100	6,100
`13`	7,364	7,364	7,364	7,364	7,364	7,364	7,364	7,364	7,364
`130/1`	364	364	364	7,364	7,364	7,364	-	-	-
`130`	-	-	-	-	-	-	364	364	364
`1311`	364	364	364	7,364	7,364	7,364	-	-	-
`132`	7,000	7,000	7,000	-	-	-	7,000	7,000	7,000
`14`	2,687	-2,404	-9,409	14,972	30,068	33,864	20,774	16,460	6,908
`17/49`	9,187	10,287	16,755	17,381	18,569	34,509	7,004	14,128	511
`42/48`	9,187	10,287	16,755	17,381	18,569	34,509	7,004	14,128	511
`43`	-	-	-	9	-	-	-	-	-
`430/8`	-	-	-	9	-	-	-	-	-
`44`	385	794	1,018	802	317	3,160	439	5,121	21
`440/4`	385	794	1,018	802	317	3,160	439	5,121	21
`45`	1,602	7,478	14,456	7,718	17,252	19,306	6,565	4,898	81
`450/3`	336	1,260	5,665	146	10,210	13,764	2,387	3,693	-
`454/9`	1,266	6,218	8,791	7,572	7,042	5,542	4,178	1,205	81
`47/48`	7,200	2,015	1,281	8,852	1,000	12,043	-	4,109	409
Income statement
`70`	-	-	-	-	-	-	-	109,372	38,496
`76A`	8,194	15,859	-	13,829	12,203	23,433	-	-	-
`9900`	15,584	47,824	16,740	-41,794	-57,050	-26,622	-25,887	-15,328	18,621
`60/61`	-	-	-	-	-	-	-	124,712	19,875
`62`	1,653	37,669	44,248	39,189	35,037	24,274	24,773	19,276	4,107
`630`	1,438	1,847	2,209	2,226	1,887	2,439	2,408	1,853	-
`640/8`	58	998	930	528	645	495	334	8,166	319
`66A`	-	-	-	-	-	69	-	-	-
`9901`	12,435	7,310	-30,647	-83,737	-94,619	-53,899	-53,402	-44,623	14,195
`75/76B`	134	-	6,597	68,758	91,034	93,125	56,443	56,875	101
`75`	134	-	6,597	68,758	91,034	93,125	56,443	56,875	101
`65/66B`	137	131	211	117	101	102	52	222	25
`65`	137	131	211	117	101	102	52	222	25
`9903`	12,432	7,179	-24,261	-15,096	-3,686	39,124	2,989	12,030	14,271
`67/77`	141	174	120	-	110	8,829	-1,325	2,478	-
`9904`	12,291	7,005	-24,381	-15,096	-3,796	30,295	4,314	9,552	14,271
`9905`	12,291	7,005	-24,381	-15,096	-3,796	30,295	4,314	9,552	14,271
Appropriation of the result
`9906`	9,887	-2,404	-9,409	14,972	30,068	51,069	20,774	16,460	14,271
`14P`	-2,404	-9,409	14,972	30,068	33,864	-	-	-	-
`691/2`	-	-	-	-	-	-	-	-	7,363
`6920`	-	-	-	-	-	-	-	-	363
`6921`	-	-	-	-	-	-	-	-	7,000
`694/7`	7,200	-	-	-	-	17,205	-	-	-
`694`	7,200	-	-	-	-	17,205	-	-	-
Social balance sheet
`9087`	1	1	1	1	0.9	0.8	0.8	-	-
Hours worked`1013`	-	1,208	1,520	1,702	1,530	1,277	1,300	-	-
Document	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF

The notes to these accounts have 4 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 22-06-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank

Financial year	Type	Filed	Reference	Document
31-12-2025	micro format	22-06-2026	2026-00181231	PDF
31-12-2024	micro format	16-06-2025	2025-00146134	PDF
31-12-2023	micro format	17-06-2024	2024-00133615	PDF
31-12-2022	micro format	23-06-2023	2023-00151472	PDF
31-12-2021	micro format	20-06-2022	2022-20091415	PDF
31-12-2020	micro format	15-06-2021	2021-20000275	PDF
31-12-2019	micro format	15-06-2020	2020-16800594	PDF
31-12-2018	micro format	10-07-2019	2019-31300492	PDF
31-12-2017	micro format	25-10-2018	2018-70600072	PDF

Key figures and ratios

per financial year, computed from the annual accounts

2025	2024	2023	2022	2021	2020	2019	2018	2017
13,873	9,157	-28,438	-81,511	-92,732	-51,460	-50,994	-42,770	-
13,729	8,852	-22,172	-12,870	-1,909	32,734	6,722	11,405	-
0	0	0	0	10,729	4,781	0	7,810	-
1,947	2,986	-17,940	-2,970	-28,609	34,911	-3,432	8,373	-
16,057	9,528	676	22,848	35,718	48,356	37,608	30,886	26,772
-	-	-	-	-	-	-	-40.8%	36.9%
71.1%	62.9%	38.4%	66.7%	72.9%	60.9%	85.3%	72.0%	98.1%
2.75	1.93	1.04	2.31	2.92	2.40	6.37	3.19	53.39
0.41	0.59	1.60	0.50	0.37	0.64	0.17	0.39	0.02
54.5%	40.1%	-233.2%	-43.3%	-7.6%	56.4%	10.6%	26.3%	53.3%
38.7%	25.2%	-89.6%	-28.9%	-5.5%	34.3%	9.1%	18.9%	52.3%
over 100	69.90	-134.78	-696.68	-918.14	-	-	-	-
-	-	-	-	-	-	-	25 days	1 day
-	-	-	-	-	-	-	15 days	0 days

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Social balance sheet

Item	31-12-2025	31-12-2024	31-12-2023	31-12-2022	31-12-2021
Employees at the balance-sheet date	1	1	1	1	1
full-time	1	1	1	1	1
in full-time equivalents	1	1	1	1	1
	1	1	1	1	0.9
On a permanent contract	1	1	1	1	1

Source: social balance sheet in the 2021 to 2025 annual accounts

Investments

fixed assets acquired

Item	2025	2024	2023	2022	2021
Tangible fixed assets	-	-	-	-	€10,729
	€1,438	€1,847	€2,209	€2,226	€1,887

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on M C E

The operating result for 2025 is 70% higher than in 2024 and the highest since 2017. It is the fourth rise in a row, after the fall in 2021.

Debt's share of the balance-sheet total falls from 37.1% to 28.9%. Equity is higher and debt is lower.

Board & ownership

Board

3 directors, no change since 2024

Manager (not named in the articles)

since 25-08-2017

listed in the 2021 annual accounts, filed on 20-06-2022

Director

since 06-03-2018 6-year term from 2023

listed in the 2021 annual accounts, filed on 20-06-2022

Director

appointed by deed of 20-04-2023 6-year term from 2023

Signing authority: “Article 14 : Pouvoirs de l’administrateur - Représentation L'administrateur a le pouvoir d'accomplir tous les actes nécessaires ou utiles à…”
deed of 20-04-2023

Office holders in the KBO →

Mandates through the years

5 names, the dashed line is today

Manager (not named in the articles)

Manager

Director

Manager (not named in the articles)

BoardEarlierRest of the termmandate already running before its first mentionend not dated

Mandates as a list

- Manager (not named in the articles), from 25-08-2017 to date
- Manager, from 06-03-2018 to date
- Director, appointed by deed of 20-04-2023, still in office
- Director, until 31-12-2024
- Manager (not named in the articles), appointed by deed of 29-08-2017, until 30-09-2017
- Manager (not named in the articles), appointed by deed of 29-08-2017, no longer listed in the 2021 annual accounts

See the board, name and registered office on a given date →

Control

Shares transferred to

This company

M C E

Equity €22,551

Profit €12,291 in 2025

Capital

Contribution: €12,500
Shares: 186
Contribution per share: €67.20
Equity per share: €121 in 2025
Source: 2025 annual accounts

Articles of association

deed of 20-04-2023 (in French)

Duration: Unlimited
Board rule: At least 1 director
Annual meeting: Second Friday of June at 18:00

Shareholders

Share transfer deed of 23-05-2018 ↗

Stated in the deed deed of 16-10-2017 ↗

all shares

At incorporation deed of 29-08-2017 ↗

186 shares (100%) · €18,600

Capital transactions

Capital over time

20-04-2023 Converted to unavailable equity
29-08-2017 Incorporation · €18,600 · 186 shares

Network & group

No group

M C E has no parent and no holdings in its annual accounts. M C E shares no director with another company.

At the same address

Oudergemlaan 239, 1040 Etterbeek · 2 other companies

ALECU MEDICAL establishment since 31-12-2009 · founded in 2009	total assets €695,610 (2025) 0821.903.170
Association des Copropriétaires Résidence Copropriété 239-241 à Etterbeek, avenue d'Auderghem 239-241 registered office since 06-05-2004	founded in 2004 0865.474.778

Timeline

18 events since 2017

Board

Capital

Filings

Financial

Establishments

20182020202220242026

Deadline for the 2026 accounts: 31-07-2027

2026

22-06-2026

Annual accounts 2025 filed NBBmicro format · 39 days before the deadline

2025

16-06-2025

Annual accounts 2024 filed PDFmicro format · 45 days before the deadline

24-01-2025

Resignation: (director)Board meeting of 02-01-20252 points ▸

Board meeting, 02-01-2025
Director resignation,

Open the deed in the Belgian Official Gazette

2024

31-12-2024

Back to profit net €7,005 The net result is €7,005, after 3 loss-making years.

17-06-2024

Annual accounts 2023 filed PDFmicro format · 44 days before the deadline

2023

31-12-2023

Weakest financial year net -€24,381 The net result drops to -€24,381, the lowest from 2017 to 2025. It recovers the following year.

23-06-2023

Annual accounts 2022 filed PDFmicro format · 38 days before the deadline

20-04-2023

Appointments: (director) and (director)General meeting of 13-04-20235 points ▸

General meeting, 13-04-2023
186 shares
Director appointment,
Director appointment,
Registered office clause, Avenue d'Auderghem 239, 1040 Etterbeek
The deed holds 5 more points.

Open the deed in the Belgian Official Gazette

2022

20-06-2022

Annual accounts 2021 filed PDFmicro format · 41 days before the deadline

2021

15-06-2021

Annual accounts 2020 filed PDFmicro format · 46 days before the deadline

2020

31-12-2020

Highest result from 2017 to 2025 net €30,295 ▲602% The net result of €30,295 is the highest of those years.

15-06-2020

Annual accounts 2019 filed PDFmicro format · 46 days before the deadline

2019

10-07-2019

Annual accounts 2018 filed PDFmicro format · 21 days before the deadline

2018

25-10-2018

Annual accounts 2017 filed PDFmicro format · 86 days late

23-05-2018

Appointment: (manager)Transfer of shares from to · General meeting of 2018-033 points ▸

General meeting, 2018-03
Share transfer,
Director appointment, (manager)

Open the deed in the Belgian Official Gazette

2017

16-10-2017

Resignation: (manager) holds all the shares · General meeting of 30-09-20173 points ▸

General meeting, 30-09-2017
holds all the shares
Director resignation, (manager)

Open the deed in the Belgian Official Gazette

01-10-2017

First establishment Oudergemlaan 239, Etterbeek

25-08-2017

IncorporationFounding capital of €18,600, 186 shares, €12,400 paid up · Founder: (comparant) · Appointments: (manager) and (manager) · published on 29-08-20175 points ▸

Founder, (comparant)
Founding capital, €18,600, 186 shares
Capital, €18,600, 186 shares
Director appointment, (manager (not named in the articles))
Director appointment, (manager (not named in the articles))
The deed holds 3 more points.

Open the deed in the Belgian Official Gazette

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official Gazette Filings with the National Bank

History

On 25 August 2017, M C E was incorporated by one natural person, with a starting capital of €18,600.¹² Today the board has 3 members.³ Total assets went from €50,452 in 2018 to €31,738 in 2025 and headcount from 0.8 full-time equivalents in 2019 to 1 in 2025.⁴

Company details

Identity

Enterprise number: 0680.438.766
VAT number: BE 0680.438.766
Legal form: Private limited company
Status: Active, normal situation
Founded: 25-08-2017
Financial year: ends on 31 December
Annual meeting: Second Friday of June at 18:00
deed of 20-04-2023 (in French)
Peppol: Not found in the Peppol Directory
Name: M C E in French
Entity type: Legal entity
Duration: Unlimited
deed of 20-04-2023 (in French)
Registered office clause: “Région de Bruxelles-Capitale”
deed of 20-04-2023 (in French)

Activities

NACEBEL 2025

86210 General medical practice main activity

Joint committees annual accounts 2025

JC 330 Health institutions and services

Codes under NACEBEL 2008

86210 General medical practice main activity

Purpose: “Faire tout acte nécessaire et/ou indispensable à l’accomplissement de son objet et plus particulièrement toute transaction mobilière et…”
2 activities
Faire tout acte nécessaire et/ou indispensable à l’accomplissement de son objet et plus particulièrement toute transaction mobilière et immobilière concernant les locaux médicaux,achat de matériel médical et non médical,engagement du personnel administratif,soignant,pratiquant ou appelé à pratiquer dans la société
Exercice en son nom et pour son compte de la médecine générale et/ou spécialisée par l’intermédiaire de ses organes médecins légalement habilités à pratiquer l’art de guérir en Belgique,plus particulièrement pratique radiologique,imagerie médicale,exercice de toute discipline connexe ou non,exécution de tout acte technique et médical en rapport avec ces disciplines et gestion de tous moyens destinés à en améliorer l’exercice
deed of 20-04-2023 (in French)

Registered office and establishments

1 establishment

Establishment	Since	Unit number
Oudergemlaan 239 registered office 1040 Etterbeek	01-10-2017	2.268.658.467

Buildings and parcels at the address

Ground area: 1,039 m²
Buildings: 183 m²
Volume, LiDAR: 2,543 m³
Tallest building: 19.3 m

Buildings to scale, each on its own parcel

registered office establishment The establishment unit on the map

3 companies at this address See who is registered here

Parcels

Cadastral parcel	Area	Buildings	Height / floors
21364B0028/00C004	1,039 m²	1 · 183 m²	19.3 m · 5

Invoicing and payment

E-invoicing via Peppol

Being listed in the Peppol Directory is voluntary, so the company can still receive invoices via Peppol.

Invoicing without a Peppol listing

Try sending from your invoicing software. If that fails, ask the customer whether they already receive via Peppol.

The obligation holds between Belgian VAT-registered businesses. Checked does not know whether this customer is VAT-registered. If it is and is not ready yet, you may send the invoice another way, for example as a PDF. To send it electronically you then need its agreement on a secure channel. The invoice remains valid, and it is then the customer, not you, who risks a penalty. FPS Finance

Follow this company and you will hear the next morning if it appears in the Peppol register.

Overview

Lifetime

Key points

Equity

Turnover

Liquidity

Filings

Starting capital

Position in the sector

Checked score

Score breakdown

Comparable companies, two years later

Credit verdict

Signals

Board and ownership

Recent changes

Comparable companies

Official details

Annual accounts 2025

Insights on M C E

Financials

Annual accounts 2025

Money flows

Balance sheet

Change in equityin euro

Change in cashin euro

Position in the sector

Solvency71.1%

Current ratio2.75

Return on assets38.7%

Staff

Staff cost per FTE€1,653

Filed annual accounts

Filings

Key figures and ratios

Social balance sheet

Investments

Insights on M C E

Board & ownership

Board

Mandates through the years

Control

Capital

Articles of association

Shareholders

Capital transactions

Network & group

No group

At the same address

Timeline

Timeline

History

Company details

Identity

Activities

Registered office and establishments

Buildings and parcels at the address

Location

Parcels

Invoicing and payment

in euro

in euro

71.1%

2.75

38.7%

€1,653